Showing results (131-140 of 212) with videos related to

Sort By:
Pageof 22
Diabetes & Metabolism|January 25, 2019
Efficacy and adherence of glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes mellitus in real-life settingsB Guerci, B Charbonnel, P Gourdy, et al.
Diabetologia|November 13, 2007
Evaluating the association of common LMNA variants with type 2 diabetes and quantitative metabolic phenotypes in French EuropidsK Duesing, G Charpentier, M Marre, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|August 1, 1996
[Decrease of nocturnal blood pressure in type II diabetic subjects with microalbuminuria]G Berrut, P Fabbri, B Bouhanick, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 9, 2002
[Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes]A Fanelli, S Hadjadj, Y Gallois, et al.
American Journal of Hypertension|September 30, 1998
Ambulatory blood pressure and urinary albumin excretion in diabetic (non-insulin-dependent and insulin-dependent) hypertensive patients: relationships at baseline and after treatment by the angiotensin converting enzyme inhibitor trandolaprilB Bauduceau, N Genès, B Chamontin, et al.
Diabetologia|May 6, 2005
Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjectsS Hadjadj, R Aubert, F Fumeron, et al.
Diabetes, Obesity & Metabolism|April 19, 2003
Influence of initial hyperglycaemia, weight and age on the blood glucose lowering efficacy and incidence of hypoglycaemic symptoms with a single-tablet metformin-glibenclamide therapy (Glucovance) in type 2 diabetesA Garber, M Marre, L Blonde, et al.
International Ophthalmology|December 1, 1986
Study of the first hundred phakic eyes treated by peripheral iridotomy using the N.D. Yag laserJ Haut, I Gaven, F Moulin, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|March 1, 1991
[Dissociation of hypotensive and renal hemodynamic effects of an angiotensin converting enzyme inhibitor in insulin-dependent diabetic patients with incipient nephropathy]M Hallab, A Billiard, J J Lejeune, et al.
Diabetes & Metabolism|November 17, 2009
Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain: 52-week data from the PREDICTIVE study in a cohort of French patients with type 1 or type 2 diabetesM Marre, M Pinget, H Gin, et al.
Pageof 22